April 8, 2026 · Form 4 insider transaction
Zummo Jacqueline sold 1,134 shares of Protara Therapeutics, Inc. at $5.40 per share, a transaction worth $6.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025.